Paulson Richard A.
Insider CIK 1804460 · BLUE Director · KPTI President and CEO, Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| KPTI Karyopharm Therapeutics In | S Sale | 2026-05-14 | 2026-05-15 | 2,203 | $9.50 | $20.9K | 269,747 | SEC↗ |
| KPTI Karyopharm Therapeutics In | A Award | 2026-05-13 | 2026-05-15 | 4,920 | — | $0 | 271,950 | SEC↗ |
| KPTI Karyopharm Therapeutics In | S Sale | 2026-03-02 | 2026-03-03 | 12,361 | $9.41 | $116.3K | 267,030 | SEC↗ |
| KPTI Karyopharm Therapeutics In | A Award | 2026-02-05 | 2026-02-09 | 81,060 | — | $0 | 279,391 | SEC↗ |
| KPTI Karyopharm Therapeutics In | A Award | 2025-10-15 | 2025-10-16 | 114,285 | — | $0 | 198,331 | SEC↗ |
| KPTI Karyopharm Therapeutics In | S Sale | 2025-09-15 | 2025-09-16 | 1,257 | $6.43 | $8.1K | 84,046 | SEC↗ |
| KPTI Karyopharm Therapeutics In | A Award | 2025-09-12 | 2025-09-16 | 2,800 | — | $0 | 85,303 | SEC↗ |
| BLUE bluebird bio, Inc. | D To issuer | 2025-06-02 | 2025-06-03 | 1,323 | — | $0 | 0 | SEC↗ |
| BLUE bluebird bio, Inc. | U Tender | 2025-05-30 | 2025-06-03 | 155 | — | $0 | 1,323 | SEC↗ |
| KPTI Karyopharm Therapeutics In | S Sale | 2025-05-06 | 2025-05-07 | 236 | $7.12 | $1.7K | 82,503 | SEC↗ |
| KPTI Karyopharm Therapeutics In | S Sale | 2025-04-04 | 2025-04-07 | 245 | $3.74 | $916 | 82,739 | SEC↗ |
| KPTI Karyopharm Therapeutics In | S Sale | 2025-03-04 | 2025-03-06 | 11,694 | $6.29 | $73.6K | 82,984 | SEC↗ |
| KPTI Karyopharm Therapeutics In | A Award deriv | 2025-02-28 | 2025-03-04 | 40,000 | — | $0 | 40,000 | SEC↗ |
| KPTI Karyopharm Therapeutics In | A Award | 2025-02-28 | 2025-03-04 | 20,000 | — | $0 | 94,678 | SEC↗ |
| KPTI Karyopharm Therapeutics In | S Sale | 2025-02-04 | 2025-02-05 | 4,099 | $0.65 | $2.7K | 1,120,158 | SEC↗ |
| KPTI Karyopharm Therapeutics In | S Sale | 2025-01-06 | 2025-01-07 | 4,055 | $0.78 | $3.2K | 1,124,257 | SEC↗ |
| KPTI Karyopharm Therapeutics In | S Sale | 2024-12-04 | 2024-12-05 | 3,620 | $0.81 | $2.9K | 1,128,312 | SEC↗ |
| BLUE bluebird bio, Inc. | A Award deriv | 2024-11-06 | 2024-11-08 | 49,850 | — | $0 | 49,850 | SEC↗ |
| BLUE bluebird bio, Inc. | A Award | 2024-11-06 | 2024-11-08 | 24,900 | — | $0 | 29,563 | SEC↗ |
| KPTI Karyopharm Therapeutics In | S Sale | 2024-11-05 | 2024-11-06 | 3,675 | $0.91 | $3.3K | 1,131,932 | SEC↗ |
| KPTI Karyopharm Therapeutics In | S Sale | 2024-10-04 | 2024-10-07 | 3,607 | $0.88 | $3.2K | 1,135,607 | SEC↗ |
| KPTI Karyopharm Therapeutics In | S Sale | 2024-09-04 | 2024-09-05 | 3,667 | $0.72 | $2.6K | 1,139,214 | SEC↗ |
| KPTI Karyopharm Therapeutics In | S Sale | 2024-08-06 | 2024-08-08 | 3,608 | $0.93 | $3.4K | 1,142,881 | SEC↗ |
| KPTI Karyopharm Therapeutics In | S Sale | 2024-07-05 | 2024-07-09 | 3,616 | $0.85 | $3.1K | 1,146,489 | SEC↗ |
| KPTI Karyopharm Therapeutics In | S Sale | 2024-06-04 | 2024-06-06 | 3,592 | $0.99 | $3.6K | 1,150,105 | SEC↗ |
| KPTI Karyopharm Therapeutics In | S Sale | 2024-05-06 | 2024-05-07 | 3,576 | $1.13 | $4.0K | 1,153,697 | SEC↗ |
| KPTI Karyopharm Therapeutics In | S Sale | 2024-04-04 | 2024-04-05 | 3,563 | $1.29 | $4.6K | 1,157,273 | SEC↗ |
| KPTI Karyopharm Therapeutics In | S Sale | 2024-03-05 | 2024-03-06 | 3,573 | $1.30 | $4.6K | 1,160,836 | SEC↗ |
| KPTI Karyopharm Therapeutics In | S Sale | 2024-03-01 | 2024-03-04 | 19,374 | $1.20 | $23.2K | 1,164,409 | SEC↗ |
| KPTI Karyopharm Therapeutics In | S Sale | 2024-02-29 | 2024-03-04 | 80,470 | $1.17 | $94.1K | 1,183,783 | SEC↗ |
| KPTI Karyopharm Therapeutics In | A Award | 2024-02-28 | 2024-02-29 | 442,800 | — | $0 | 1,264,253 | SEC↗ |
| KPTI Karyopharm Therapeutics In | S Sale | 2024-02-06 | 2024-02-08 | 4,012 | $1.59 | $6.4K | 821,453 | SEC↗ |
| KPTI Karyopharm Therapeutics In | A Award | 2024-01-24 | 2024-01-25 | 42,000 | — | $0 | 825,465 | SEC↗ |
| KPTI Karyopharm Therapeutics In | S Sale | 2024-01-04 | 2024-01-08 | 4,114 | $0.82 | $3.4K | 783,465 | SEC↗ |
| KPTI Karyopharm Therapeutics In | S Sale | 2023-12-04 | 2023-12-05 | 3,622 | $0.79 | $2.9K | 787,579 | SEC↗ |
| KPTI Karyopharm Therapeutics In | S Sale | 2023-11-06 | 2023-11-07 | 3,606 | $0.92 | $3.3K | 791,201 | SEC↗ |
| KPTI Karyopharm Therapeutics In | S Sale | 2023-10-04 | 2023-10-05 | 3,589 | $1.27 | $4.6K | 794,807 | SEC↗ |
| KPTI Karyopharm Therapeutics In | S Sale | 2023-09-05 | 2023-09-06 | 3,558 | $1.33 | $4.7K | 798,460 | SEC↗ |
| KPTI Karyopharm Therapeutics In | S Sale | 2023-09-05 | 2023-09-06 | 64 | $1.32 | $84 | 798,396 | SEC↗ |
| KPTI Karyopharm Therapeutics In | S Sale | 2023-08-07 | 2023-08-08 | 3,722 | $1.72 | $6.4K | 802,018 | SEC↗ |
| KPTI Karyopharm Therapeutics In | S Sale | 2023-07-05 | 2023-07-06 | 3,538 | $1.72 | $6.1K | 805,740 | SEC↗ |
| KPTI Karyopharm Therapeutics In | S Sale | 2023-06-05 | 2023-06-07 | 3,536 | $2.24 | $7.9K | 809,278 | SEC↗ |
| KPTI Karyopharm Therapeutics In | S Sale | 2023-05-04 | 2023-05-05 | 3,805 | $3.35 | $12.7K | 812,814 | SEC↗ |
| KPTI Karyopharm Therapeutics In | S Sale | 2023-04-04 | 2023-04-05 | 3,497 | $3.97 | $13.9K | 816,619 | SEC↗ |
| BLUE bluebird bio, Inc. | A Award deriv | 2023-04-03 | 2023-04-05 | 7,500 | — | $0 | 7,500 | SEC↗ |
| BLUE bluebird bio, Inc. | A Award | 2023-04-03 | 2023-04-05 | 4,663 | — | $0 | 4,663 | SEC↗ |
| KPTI Karyopharm Therapeutics In | S Sale | 2023-03-06 | 2023-03-07 | 3,506 | $3.16 | $11.1K | 820,116 | SEC↗ |
| KPTI Karyopharm Therapeutics In | S Sale | 2023-03-01 | 2023-03-02 | 33,033 | $3.03 | $100.1K | 823,622 | SEC↗ |
| KPTI Karyopharm Therapeutics In | A Award | 2023-02-28 | 2023-03-02 | 252,000 | — | $0 | 856,655 | SEC↗ |
| KPTI Karyopharm Therapeutics In | S Sale | 2023-02-06 | 2023-02-08 | 3,950 | $3.40 | $13.4K | 604,655 | SEC↗ |
| KPTI Karyopharm Therapeutics In | S Sale | 2023-01-04 | 2023-01-05 | 3,922 | $3.27 | $12.8K | 608,605 | SEC↗ |
| KPTI Karyopharm Therapeutics In | S Sale | 2022-12-05 | 2022-12-06 | 3,490 | $5.17 | $18.0K | 612,527 | SEC↗ |
| KPTI Karyopharm Therapeutics In | S Sale | 2022-11-04 | 2022-11-08 | 3,493 | $4.54 | $15.9K | 616,017 | SEC↗ |
| KPTI Karyopharm Therapeutics In | S Sale | 2022-10-04 | 2022-10-05 | 3,488 | $5.87 | $20.5K | 619,510 | SEC↗ |
| KPTI Karyopharm Therapeutics In | S Sale | 2022-09-08 | 2022-09-09 | 3,463 | $5.23 | $18.1K | 622,998 | SEC↗ |
| KPTI Karyopharm Therapeutics In | S Sale | 2022-09-08 | 2022-09-09 | 16 | $5.26 | $84 | 626,461 | SEC↗ |
| KPTI Karyopharm Therapeutics In | S Sale | 2022-08-04 | 2022-08-05 | 2,314 | $4.48 | $10.4K | 626,477 | SEC↗ |
| KPTI Karyopharm Therapeutics In | S Sale | 2022-07-08 | 2022-07-11 | 2,115 | $5.18 | $11.0K | 628,791 | SEC↗ |
| KPTI Karyopharm Therapeutics In | S Sale | 2022-06-07 | 2022-06-08 | 2,542 | $5.76 | $14.6K | 630,906 | SEC↗ |
| KPTI Karyopharm Therapeutics In | S Sale | 2022-05-04 | 2022-05-05 | 27,869 | $6.23 | $173.6K | 633,448 | SEC↗ |
| KPTI Karyopharm Therapeutics In | S Sale | 2022-05-04 | 2022-05-05 | 633 | $6.26 | $4.0K | 661,317 | SEC↗ |
| KPTI Karyopharm Therapeutics In | A Award deriv | 2022-02-28 | 2022-03-02 | 360,000 | — | $0 | 360,000 | SEC↗ |
| KPTI Karyopharm Therapeutics In | A Award | 2022-02-28 | 2022-03-02 | 288,750 | — | $0 | 661,950 | SEC↗ |
| KPTI Karyopharm Therapeutics In | A Award deriv | 2021-05-03 | 2021-05-04 | 559,800 | — | $0 | 559,800 | SEC↗ |
| KPTI Karyopharm Therapeutics In | A Award | 2021-05-03 | 2021-05-04 | 373,200 | — | $0 | 373,200 | SEC↗ |
| KPTI Karyopharm Therapeutics In | A Award deriv | 2020-05-21 | 2020-05-26 | 16,400 | — | $0 | 16,400 | SEC↗ |
| KPTI Karyopharm Therapeutics In | A Award deriv | 2020-03-05 | 2020-03-09 | 50,000 | — | $0 | 50,000 | SEC↗ |